Echolight, a global leader in bone densitometry, has published a new study in JBMR® Plus, the open-access journal of the American Society for Bone and Mineral Research (ASBMR)analyzing the economic impact of Radiofrequency Echographic Multi Spectrometry (REMS) for osteoporosis diagnosis in the U.S.
https://mma.prnewswire.com/media/2534197/PNG_SCRITTA_NERA__1.jpg
With osteoporosis significantly underdiagnosed, REMS presents a non-ionizing, ultrasound-based alternative to DXA, demonstrating high accuracy and precision. The study evaluates the cost-effectiveness of REMS, finding that even a modest 5% increase in diagnosis and treatment could save 30,000 life-years, 43,500 QALYs, and prevent 100,000 fractures over a lifetime.
With economic considerations playing an increasingly crucial role in healthcare decisions, the cost-effectiveness and economic impact (in terms of health outcomes and costs) of improved osteoporosis diagnosis using REMS followed by treatment in the United States has been evaluated and detailed in the newly released-paper entitled “Cost-effectiveness of radiofrequency echographic multi-spectrometry for the diagnosis of osteoporosis in the United States”.
Mike Yuja, Chief Commercial Officer and General Manager explained, “This study focused on US patients and is a great collaboration between research experts from Saudi Arabia, the United States, and the Netherlands. For the first time, the significant economic benefits of widespread REMS implementation in clinical practice in US have been analyzed and summarized.”
In conclusion, this study suggests that “REMS is a cost-effective strategy for the diagnosis and management of osteoporosis in US women, offering substantial potential economic benefits and improved health outcomes.”
Echolightwas established in Italy with a head office in Lecce, and in 2020 opened its offices in the United States. Since then, its sales network has grown to more than 40 distributors and several hundreds of satisfied customers across the world who have adopted the innovative REMS technology for assessing the bone condition of their patients.
Created as a spin-off of the Italian National Research Council, Echolight is at the forefront of medical innovation, introducing new cutting-edge solutions to contribute to human wellbeing. It has been awarded all the standard certificates: UNI CEI EN ISO 13485: 2016, Quality Management System UNI EN ISO 9001: 2015, CE mark, FDA clearance, and other major certificates worldwide for innovative solutions considered as the best practice in bone health for personalized medicine.
https://c212.net/c/img/favicon.png?sn=DA16264&sd=2025-02-11
View original content to download multimedia:https://www.prnewswire.com/news-releases/echolight-announces-new-study-on-economic-impact-of-rems-implementation-in-clinical-practice-302373442.html
SOURCE Echolight Medical
https://rt.newswire.ca/rt.gif?NewsItemId=DA16264&Transmission_Id=202502111000PR_NEWS_USPR_____DA16264&DateId=20250211